InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022
$0.80 -1.68% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.80 −72.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.5Operating income−136.5Net income−135.7Fiscal year 2017Revenue181.2 +11,706.3%Operating income−76.7Net income−73.7Fiscal year 2018Revenue207.7 +14.6%Operating income−178.2Net income−143.6Fiscal year 2019Revenue335.0 +61.3%Operating income−286.3Net income−279.7EPS, diluted−2.36Fiscal year 2020Revenue294.6 −12.0%Operating income−377.8Net income−384.8EPS, diluted−2.78Fiscal year 2021Revenue211.7 −28.2%Operating income−264.5Net income−282.0EPS, diluted−1.70Fiscal year 2022Revenue292.5 +38.2%Operating income−80.8Net income−94.2EPS, diluted−0.52Fiscal year 2023Revenue194.6 −33.5%Operating income−46.3Net income−51.9EPS, diluted−0.28Fiscal year 2024Revenue160.2 −17.7%Operating income−50.5Net income−69.4EPS, diluted−0.33Fiscal year 2025Revenue236.2 +47.5%Operating income23.5Net income−5.3EPS, diluted−0.02
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.5 181.2 207.7 335.0 294.6 211.7 292.5 194.6 160.2 236.2
Growth +11,706.3% +14.6% +61.3% −12.0% −28.2% +38.2% −33.5% −17.7% +47.5%
Operating income −136.5 −76.7 −178.2 −286.3 −377.8 −264.5 −80.8 −46.3 −50.5 23.5
Net income −135.7 −73.7 −143.6 −279.7 −384.8 −282.0 −94.2 −51.9 −69.4 −5.3
Growth
EPS, diluted n/a n/a n/a −2.36 −2.78 −1.70 −0.52 −0.28 −0.33 −0.02
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−8,889.9%Net margin−8,843.5%Free cash flow margin3,599.0%Fiscal year 2017Operating margin−42.3%Net margin−40.7%Free cash flow margin−31.9%Fiscal year 2018Operating margin−85.8%Net margin−69.1%Free cash flow margin−47.7%Fiscal year 2019Operating margin−85.5%Net margin−83.5%Free cash flow margin−78.8%Fiscal year 2020Operating margin−128.2%Net margin−130.6%Free cash flow margin−37.6%Fiscal year 2021Operating margin−125.0%Net margin−133.3%Free cash flow margin−119.5%Fiscal year 2022Operating margin−27.6%Net margin−32.2%Free cash flow margin−25.1%Fiscal year 2023Operating margin−23.8%Net margin−26.7%Free cash flow margin−12.0%Fiscal year 2024Operating margin−31.5%Net margin−43.3%Free cash flow margin−25.4%Fiscal year 2025Operating margin9.9%Net margin−2.3%Free cash flow margin28.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −8,889.9% −42.3% −85.8% −85.5% −128.2% −125.0% −27.6% −23.8% −31.5% 9.9%
Net margin −8,843.5% −40.7% −69.1% −83.5% −130.6% −133.3% −32.2% −26.7% −43.3% −2.3%
Free cash flow margin 3,599.0% −31.9% −47.7% −78.8% −37.6% −119.5% −25.1% −12.0% −25.4% 28.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow57.9Capital expenditure−2.7Free cash flow55.2Fiscal year 2017Operating cash flow−56.2Capital expenditure−1.6Free cash flow−57.8 −204.6%Fiscal year 2018Operating cash flow−97.5Capital expenditure−1.6Free cash flow−99.1Fiscal year 2019Operating cash flow−257.4Capital expenditure−6.7Free cash flow−264.1Fiscal year 2020Operating cash flow−110.4Capital expenditure−0.3Free cash flow−110.7Fiscal year 2021Operating cash flow−253.0Capital expenditure−0.1Free cash flow−253.0Fiscal year 2022Operating cash flow−73.2Capital expenditure−0.1Free cash flow−73.3Fiscal year 2023Operating cash flow−23.4Capital expenditure0.0Free cash flow−23.4Fiscal year 2024Operating cash flow−40.7Capital expenditure−0.0Free cash flow−40.7Fiscal year 2025Operating cash flow68.0Capital expenditure−0.3Free cash flow67.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 57.9 −56.2 −97.5 −257.4 −110.4 −253.0 −73.2 −23.4 −40.7 68.0
Capital expenditure −2.7 −1.6 −1.6 −6.7 −0.3 −0.1 −0.1 0.0 −0.0 −0.3
Free cash flow 55.2 −57.8 −99.1 −264.1 −110.7 −253.0 −73.3 −23.4 −40.7 67.7
Growth −204.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash187.3Shareholders’ equity68.1Fiscal year 2017Cash70.2Shareholders’ equity122.6Fiscal year 2018Cash104.6Total debt15.0Net cash (debt)89.6Shareholders’ equity635.9Debt to equity0.02Fiscal year 2019Cash147.4Total debt75.8Net cash (debt)71.6Shareholders’ equity392.9Debt to equity0.19Fiscal year 2020Cash228.7Total debt96.4Net cash (debt)132.3Shareholders’ equity244.4Debt to equity0.39Fiscal year 2021Cash149.8Total debt97.5Net cash (debt)52.3Shareholders’ equity74.0Debt to equity1.32Fiscal year 2022Cash90.5Total debt66.1Net cash (debt)24.4Shareholders’ equity5.2Debt to equity12.63Fiscal year 2023Cash42.9Total debt34.7Net cash (debt)8.2Shareholders’ equity−30.6Fiscal year 2024Cash51.9Total debt38.7Net cash (debt)13.2Shareholders’ equity−49.2Fiscal year 2025Cash184.8Total debt48.3Net cash (debt)136.6Shareholders’ equity32.6Debt to equity1.48
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 187.3 70.2 104.6 147.4 228.7 149.8 90.5 42.9 51.9 184.8
Total debt n/a n/a 15.0 75.8 96.4 97.5 66.1 34.7 38.7 48.3
Net cash (debt) n/a n/a 89.6 71.6 132.3 52.3 24.4 8.2 13.2 136.6
Shareholders’ equity 68.1 122.6 635.9 392.9 244.4 74.0 5.2 −30.6 −49.2 32.6
Debt to equity n/a n/a 0.02 0.19 0.39 1.32 12.63 n/a n/a 1.48

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
57.9 −56.2 −97.5 −257.4 −110.4 −253.0 −73.2 −23.4 −40.7 68.0
Growth −197.0%
0.3 0.6 0.9 2.2 2.1 1.9 1.7 n/a n/a n/a
Investment
−2.7 −1.6 −1.6 −6.7 −0.3 −0.1 −0.1 0.0 −0.0 −0.3
calc 55.2 −57.8 −99.1 −264.1 −110.7 −253.0 −73.3 −23.4 −40.7 67.7
Growth −204.6%
calc n/a n/a n/a −2.23 −0.80 −1.52 −0.40 −0.12 −0.19 0.26
12.7 −177.3 36.6 211.2 −40.0 39.9 −0.1 0.0 −0.0 −7.9
Financing
66.9 116.2 96.6 89.0 231.7 133.7 14.6 −25.2 49.7 72.9

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.